FDA Approved: AZOR — Original Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved AZOR, a fixed-dose combination of amlodipine besylate and olmesartan medoxomil, under Cosette Pharmaceuticals' original application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• AZOR (Amlodipine besylate and olmesartan medoxomil)

Snippet

ORIG AP for AZOR (AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL)